Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Mobile wireless device with multi-band antenna and related methods
Terminal structure, electronic device, and manufacturing method thereof
Curable composition
Multiple device types including an inverted-T channel transistor and method therefor
Surgical compositions for reducing the incidence of adhesions
Hinge and flip device with the same
Rendering control method in which a processor and a hardware accelerator can be used efficiently
  Randomly Featured Patents
Liquid crystal display screen
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
Press system with interleaved embossing foil holders for nano-imprinting of recording media
Fiber-reactive disazo and tetrakisazo halotriazinyl dyes
Reactor head with integral nozzles
Controlling bias current for an analog to digital converter
Liquid crystal display devices and manufacturing method thereof
Persisting a group in an instant messaging application
Saucer sled
Surface treatment of a tin-plate